Genomic characterization of Achromobacter species isolates from chronic and occasional lung infection in cystic fibrosis patients

被引:17
|
作者
Veschetti, Laura [1 ]
Sandri, Angela [2 ]
Patuzzo, Cristina [1 ]
Melotti, Paola [3 ]
Malerba, Giovanni [1 ]
Lleo, Maria M. [2 ]
机构
[1] Univ Verona, Dept Neurosci Biomed & Movement Sci, I-37134 Verona, Italy
[2] Univ Verona, Dept Diagnost & Publ Hlth, Microbiol Sect, I-37134 Verona, Italy
[3] Azienda Osped Univ Integrata Verona, Cyst Fibrosis Ctr, I-37126 Verona, Italy
来源
MICROBIAL GENOMICS | 2021年 / 7卷 / 07期
关键词
Achromobacter; cystic fibrosis; lung infection; bacterial evolution; comparative genomics; virulence factors; antibiotic resistance; hypermutation; HYPERMUTABLE PSEUDOMONAS-AERUGINOSA; METALLO-BETA-LACTAMASE; MOLECULAR CHARACTERIZATION; GENETIC ADAPTATION; XYLOSOXIDANS; PREVALENCE; RESISTANCE; DATABASE; STRAINS;
D O I
10.1099/mgen.0.000606
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Achromobacter species are increasingly being detected in cystic fibrosis (CF) patients, where they can establish chronic infections by adapting to the lower airway environment. To better understand the mechanisms contributing to a successful colonization by Achromobacter species, we sequenced the whole genome of 54 isolates from 26 patients with occasional and early/late chronic lung infection. We performed a phylogenetic analysis and compared virulence and resistance genes, genetic variants and mutations, and hypermutability mechanisms between chronic and occasional isolates. We identified five Achromobacter species as well as two non- affiliated genogroups (NGs). Among them were the frequently isolated Achromobacter xylosoxidans and four other species whose clinical importance is not yet clear: Achromobacter insuavis, Achromobacter dolens, Achromobacter insolitus and Achromobacter aegrifaciens. While A. insuavis and A. dolens were isolated only from chronically infected patients and A. aegrifaciens only from occasionally infected patients, the other species were found in both groups. Most of the occasional isolates lacked functional genes involved in invasiveness, chemotaxis, type 3 secretion system and anaerobic growth, whereas the great majority ( 1 year from first colonization) and 78% of late chronic ( 1 year from first colonization) isolates were classified as hypermutators. Although all A. dolens, A. insuavis and NG isolates presented two different mutS genes, these seem to have a complementary rather than compensatory function. In conclusion, our results show that Achromobacter species can exhibit different adaptive mechanisms and some of these mechanisms might be more useful than others in establishing a chronic infection in CF patients, highlighting their importance for the clinical setting and the need for further studies on the less clinically characterized Achromobacter species.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Mobilome Analysis of Achromobacter spp. Isolates from Chronic and Occasional Lung Infection in Cystic Fibrosis Patients
    Veschetti, Laura
    Sandri, Angela
    Patuzzo, Cristina
    Melotti, Paola
    Malerba, Giovanni
    Lleo, Maria M.
    MICROORGANISMS, 2021, 9 (01) : 1 - 10
  • [2] Prevalence of hypermutator isolates of Achromobacter spp. from cystic fibrosis patients
    Ridderberg, Winnie
    Handberg, Kurt Jensen
    Norskov-Lauritsen, Niels
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2020, 310 (02)
  • [3] Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis
    Somayaji, Ranjani
    Stanojevic, Sanja
    Tullis, D. Elizabeth
    Stephenson, Anne L.
    Ratjen, Felix
    Waters, Valerie
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (09) : 1412 - 1418
  • [4] What is the role of Achromobacter species in patients with cystic fibrosis?
    Esposito, Susanna
    Pisi, Giovanna
    Fainardi, Valentina
    Principi, Nicola
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2021, 26 (12): : 1613 - 1620
  • [5] In Vitro Susceptibility of Achromobacter Species Isolated from Cystic Fibrosis Patients: a 6-Year Survey
    Olbrecht, Margo
    Echahidi, Fedoua
    Pierard, Denis
    Peeters, Charlotte
    Vandamme, Peter
    Wybo, Ingrid
    Demuyser, Thomas
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023, 67 (07)
  • [6] Diversity of Achromobacter species recovered from patients with cystic fibrosis, in Argentina
    Papalia, Mariana
    Steffanowski, Carla
    Traglia, German
    Almuzara, Marisa
    Martina, Pablo
    Galanternik, Laura
    Vay, Carlos
    Gutkind, Gabriel
    Soledad Ramirez, Maria
    Radice, Marcela
    REVISTA ARGENTINA DE MICROBIOLOGIA, 2020, 52 (01): : 13 - 18
  • [7] Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia
    Rees, Vanessa E.
    Lucas, Deanna S. Deveson
    Lopez-Causape, Carla
    Huang, Yuling
    Kotsimbos, Tom
    Bulitta, Jurgen B.
    Rees, Murray C.
    Barugahare, Adele
    Peleg, Anton Y.
    Nation, Roger L.
    Oliver, Antonio
    Boyce, John D.
    Landersdorfer, Cornelia B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (04)
  • [8] Adaptive Interactions of Achromobacter spp. with Pseudomonas aeruginosa in Cystic Fibrosis Chronic Lung Co-Infection
    Sandri, Angela
    Haagensen, Janus Anders Juul
    Veschetti, Laura
    Johansen, Helle Krogh
    Molin, Soren
    Malerba, Giovanni
    Signoretto, Caterina
    Boaretti, Marzia
    Lleo, Maria M.
    PATHOGENS, 2021, 10 (08):
  • [9] Molecular Characterization of Achromobacter Isolates from Cystic Fibrosis and Non-Cystic Fibrosis Patients in Madrid, Spain
    Barrado, Laura
    Branas, Patricia
    Angeles Orellana, M.
    Teresa Martinez, M.
    Garica, Gloria
    Otero, Joaquin R.
    Chaves, Fernando
    JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (06) : 1927 - 1930
  • [10] Achromobacter Species Isolated from Cystic Fibrosis Patients Reveal Distinctly Different Biofilm Morphotypes
    Nielsen, Signe M.
    Norskoy-Lauritsen, Niels
    Bjarnsholt, Thomas
    Meyer, Rikke L.
    MICROORGANISMS, 2016, 4 (03)